Is MDWD or RGC more undervalued in 2026?

CirclFi compares MediWound Ltd. (MDWD) and Regencell Bioscience Holdings L (RGC) using 13 institutional-grade valuation models. MDWD has a Quality of Company score of 1.8/10 while RGC scores 4.6/10.

Which is a better buy — MDWD or RGC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MDWD and RGC valuations compare?

MDWD at $14.33 and RGC at $23.90 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MDWD vs RGC Valuation Comparison 2026 — Intrinsic Value Analysis

MDWD

Medicinal Chemicals & Botanical Products

MediWound Ltd.

Quality

1.8

out of 10

Value Trap

SAFE

Price

$14.33

Last close

Models

11/13

Active

RGC

Medicinal Chemicals & Botanical Products

Regencell Bioscience Holdings L

Quality

4.6

out of 10

Value Trap

SAFE

Price

$23.90

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	MDWD Fair Value	MDWD Upside	RGC Fair Value	RGC Upside
Bayesian DCF	Intrinsic	$3.34	-76.7%	$9.12	-61.8%
Earnings Power Value	Intrinsic	$1.08	-93.5%	$11.09	-59.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MDWD vs RGC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MDWD vs RGC — Which Stock Is More Undervalued?

RGC scores higher with a 4.6/10 quality rating vs MDWD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MediWound Ltd. (MDWD) and Regencell Bioscience Holdings L (RGC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MDWD currently trades at $14.33 with a QOC of 1.8/10, while RGC trades at $23.90 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).